Pko Investment Management Joint Stock CO Arvinas, Inc. Transaction History

Pko Investment Management Joint Stock CO

  • $882 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Mar 13, 2025
SELL
$26.15 - $37.26 $209,200 - $298,080
-8,000 Closed
0 $0
Q2 2022

Mar 13, 2025
BUY
$36.01 - $74.24 $126,035 - $259,839
3,500 Added 77.78%
8,000 $337 Million
Q1 2022

Mar 13, 2025
BUY
$60.27 - $81.57 $271,215 - $367,064
4,500 New
4,500 $303 Million

Others Institutions Holding ARVN

# of Institutions
245
Shares Held
62.5M
Call Options Held
2.65M
Put Options Held
1.1M
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $392M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Pko Investment Management Joint Stock CO Portfolio

Follow Pko Investment Management Joint Stock CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pko Investment Management Joint Stock CO, based on Form 13F filings with the SEC.

News

Stay updated on Pko Investment Management Joint Stock CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email